Voyager Therapeutics (VYGR) Preferred Dividend Payments (2014 - 2015)

Voyager Therapeutics' (VYGR) quarterly Preferred Dividend Payments came in at -$4.8 million in Q4 2015, down 1046.75% year-on-year from $507000.0 in Q4 2014, and down 285.04% quarter-over-quarter from $2.6 million in Q3 2015.

Voyager Therapeutics (VYGR) Preferred Dividend Payments (2014 - 2015) Analysis & Trends

Voyager Therapeutics has disclosed Preferred Dividend Payments across 2 years of filings, most recently posting -$4.8 million for Q4 2015.

  • Preferred Dividend Payments for Q4 2015 came in at -$4.8 million, down 1046.75% year-over-year; the trailing twelve-month figure through Dec 2015 was $483000.0 (changed N/A YoY), and the FY2016 annual result was $1.2 million, down 3.61% from the prior year.
  • Preferred Dividend Payments came in at -$4.8 million for Q4 2015 at Voyager Therapeutics, down from $2.6 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $2.6 million in Q3 2015 to a low of -$4.8 million in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Voyager Therapeutics 222.52 Mn 81.04 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2015 -4.80 Mn
Sep 30, 2015 2.59 Mn
Jun 30, 2015 2.45 Mn
Mar 31, 2015 237,000.00
Dec 31, 2014 507,000.00
Sep 30, 2014 406,000.00